0001076809-25-000073.txt : 20250709 0001076809-25-000073.hdr.sgml : 20250709 20250709172147 ACCESSION NUMBER: 0001076809-25-000073 CONFORMED SUBMISSION TYPE: SCHEDULE 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20250709 DATE AS OF CHANGE: 20250709 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: IGM Biosciences, Inc. CENTRAL INDEX KEY: 0001496323 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 770349194 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SCHEDULE 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-91132 FILM NUMBER: 251114347 BUSINESS ADDRESS: STREET 1: 325 E MIDDLEFIELD ROAD CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 BUSINESS PHONE: 650-965-7873 MAIL ADDRESS: STREET 1: 325 E MIDDLEFIELD ROAD CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 FORMER COMPANY: FORMER CONFORMED NAME: Palingen, Inc. DATE OF NAME CHANGE: 20100712 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: GLAZER CAPITAL, LLC CENTRAL INDEX KEY: 0001076809 ORGANIZATION NAME: EIN: 134032491 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: SCHEDULE 13G BUSINESS ADDRESS: STREET 1: 250 WEST 55TH STREET STREET 2: SUITE 30A CITY: NEW YORK STATE: NY ZIP: 10019 BUSINESS PHONE: 212-808-7308 MAIL ADDRESS: STREET 1: 250 WEST 55TH STREET STREET 2: SUITE 30A CITY: NEW YORK STATE: NY ZIP: 10019 FORMER COMPANY: FORMER CONFORMED NAME: GLAZER CAPITAL MANAGEMENT LP DATE OF NAME CHANGE: 19990114 SCHEDULE 13G 1 primary_doc.xml SCHEDULE 13G 0001076809 XXXXXXXX LIVE Common Stock, par value $0.01 per share 07/02/2025 0001496323 IGM Biosciences, Inc. 449585108 325 E Middlefield Road Mountain View CA 94043 Rule 13d-1(c) Glazer Capital, LLC DE 0.00 2534803.00 0.00 2534803.00 2534803.00 N 7.30 IA OO Paul J. Glazer X1 0.00 2534803.00 0.00 2534803.00 2534803.00 N 7.30 IN IGM Biosciences, Inc. 325 E Middlefield Road, Mountain View, CA, 94043 This statement is filed by: (i) Glazer Capital, LLC, a Delaware limited liability company ("Glazer Capital"), with respect to the shares of Common Stock (as defined in Item 2(d)) held by certain funds and managed accounts to which Glazer Capital serves as investment manager (collectively, the "Glazer Funds"); and (ii) Mr. Paul J. Glazer ("Mr. Glazer"), who serves as the Managing Member of Glazer Capital, with respect to the shares of Common Stock held by the Glazer Funds. The foregoing persons are hereinafter sometimes collectively referred to as the "Reporting Persons." The filing of this statement should not be construed as an admission that any of the Reporting Persons is, for the purposes of Section 13 of the Act, the beneficial owner of the shares of Common Stock (as defined in Item 2(d)) reported herein. The address of the business office of each of the Reporting Persons is 250 West 55th Street, Suite 30A, New York, New York 10019. Glazer Capital is a Delaware limited liability company. Mr. Glazer is a United States citizen. Y 2,534,803 7.30% 0 2,534,803 0 2,534,803 Y N See Item 2. Y Y Y N By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11. Glazer Capital, LLC Paul J. Glazer 07/09/2025 Paul J. Glazer Paul J. Glazer 07/09/2025